References
- Epstein AE , Di Marco JP, Ellenbogen KA et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation117(21), e350–e408 (2008).
- Healey JS , HallstromAP, KuckKHet al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur. Heart J. 28(14), 1746–1749(2007).
- Santangeli P , DiBL, DelloRAet al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann. Intern. Med. 153(9), 592–599(2010).
- Chan PS , NallamothuBK, SpertusJAet al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ. Cardiovasc. Qual. Outcomes 2(1), 16–24(2009).
- Epstein AE , KayGN, PlumbVJet al. Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm 6(8), 1136–1143(2009).
- Koplan BA , EpsteinLM, AlbertCM, StevensonWG. Survival in octogenarians receiving implantable defibrillators. Am. Heart J.152(4), 714–719(2006).
- Lee DS , TuJV, AustinPCet al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J. Am. Coll. Cardiol. 49(25), 2408–2415(2007).
- Tsai V , GoldsteinMK, HsiaHH, WangY, CurtisJ, HeidenreichPA. Age differences in primary prevention implantable cardioverter-defibrillator use in US individuals. J. Am. Geriatr. Soc.59(9), 1589–1595(2011).
- Yung D , BirnieD, DorianPet al. Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation 127(24), 2383–2392(2013).
- MacFadden DR , CrystalE, KrahnADet al. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann. Intern. Med. 156(3), 195–203(2012).
- Germano JJ , ReynoldsM, EssebagV, JosephsonME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am. J. Cardiol.97(8), 1255–1261(2006).
- Hohnloser SH , KuckKH, DorianPet al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N. Engl. J. Med. 351(24), 2481–2488(2004).
- Bigger JT . Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N. Engl. J. Med.337(22), 1569–1575(1997).
- Krahn AD , ConnollySJ, RobertsRS, GentM. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am. Heart J.147(5), 837–840(2004).